Discover a genetic mutation that opens the door for research to treat wavy stiffness

A new study, published by the “Nature” magazine, revealed that the patients with the stiffness in their cases see faster if they have a specific genetic mutation, in a result that is likely to pave the way for a new therapeutic research. And sclerosis is a relatively widespread nerve disease, as it suffers from about 3 million patients in the world, causing an imbalance in the immune organization that starts attacking an extension of neurons, the nerve axis, with the negative effects it bears, especially the motor disorders. “While this genetic mutation comes from the parents, it chases about four years in which the patient is forced to use a device to help walk,” the researcher and neurologist from the University of California and the participant in the preparation of the study said. In turn, neurologist Ruth Dobson, who was not involved in the study, confirmed that the discovery of this mutation opens a ‘possible new field for treatment’ that focuses on the brain and spinal cord. She pointed out that this goal is “still out of reach”, pointing out that it increases “great enthusiasm” among researchers who specialize in sclerosis. Researchers from 70 countries and study the new study, which is a large group of researchers from 70 countries, the gene for 12,000 patients to determine the genetic mutations that are likely to register and study the extent of the connection with the velocity of the progress of the disease. It appears that one of these mutations is linked to faster progress of the disease, and it affects Jenin, “Dysf”, which plays a role in rebuilding the affected cells and “ZnF638”, which helps control viral infection. One of the important points is that the activity of these two genes in the brain and spinal cord is concentrated, but currently therapeutic research does not focus on this field, but rather on the immune system. It has not yet been achieved after a final treatment of this disease or even a treatment that delays its progress, as current medicine improves certain symptoms, not treating the basic problem. Also read: